Monoclonal microbial developer Evelo Biosciences has completed a $50m round featuring GV, Celgene and Mayo Clinic that followed a $35m series A in 2015.

Brandless, the developer of an online budget supermarket, has emerged from stealth with $50m, $35m of which came in a recently closed series B round.

The agricultural product developer has doubled its overall equity funding, closing a round led by corporate venturing unit Monsanto Growth Ventures.

The retail pricing intelligence platform has secured series B funding, three years after raising capital from Swift Communications and McClatchy Company.

Online clothing modelling platform Metail has received $12.9m from TAL Group, which had teamed with Perform Group to invest $12m in the company three years ago.

AGL Energy, Southern Company and GE Ventures were among the participants in a series B round that took energy optimisation company AMS's total equity funding to $52m.

Alibaba and SBI Group have come on board as investors, in a series B round that boosted the Southeast Asian financial comparison platform's total funding to about $95m.

The immune system-based cybersecurity software spinout based on University of Cambridge research has now raised about $180m in total.

The precision medicine company, set up by molecular biology company Qiagen and science park BioBay, will use the money to transition towards a full-fledged products company.

The immune system-based cybersecurity software provider, which counts the SoftBank and Indosat-backed SB Isat fund, has now raised about $180m in total.